PI Name Sort ascending PI Organization Title Grant Number Initiative Program Director
Valdez, Erin G

Stanford University
United States

Circadian regulation of cancer therapy-associated neuroinflammation 1R21CA267135-01A1 PAR-20-292 (R21 Clinical Trial Optional) Marge Good, R.N., M.P.H., O.C.N.
Tighiouart, Mourad

Cedars-Sinai Medical Center
United States

Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials 5U01CA232859-05 Diane St Germain, R.N., M.S., C.R.N.P.
Temel, Jennifer Sue

Massachusetts General Hospital
United States

Randomized Trial of Stepped Palliative Care versus Early Integrated Palliative Care in Patients with Advanced Lung Cancer 5R01CA215188-05 Diane St Germain, R.N., M.S., C.R.N.P.
Taratula, Oleh

Oregon State University
United States

Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia 5R37CA234006-04 Alexis Bakos, Ph.D., M.P.H., R.N.
Tamrazi, Benita

Children'S Hospital Of Los Angeles
United States

Brain iron accumulation as an in vivo quantifiable biomarker of neurocognitive dysfunction in pediatric brain tumor survivors 5R21CA262978-02 PAR-20-292 (R21 Clinical Trial Optional) Diane St Germain, R.N., M.S., C.R.N.P.
Suga, Jennifer Marie

Kaiser Foundation Research Institute
United States

Kaiser Permanente NCI National Community Oncology Research Program, NCORP 5UG1CA189821-09 Worta McCaskill-Stevens, M.D., M.S.
Strati, Paolo

University Of Tx Md Anderson Can Ctr
United States

Targeting Myeloid Cells to Mitigate Immune Effector Cell-Associated Neurotoxicity Syndrome in Large B-cell Lymphoma 1R21CA259694-01 Alexis Bakos, Ph.D., M.P.H., R.N.
Stover, Daniel G.

Ohio State University
United States

Video Intervention to Address Pre-Test Patient Education for Tumor Genomic Testing 1R21CA259985-01 Alexis Bakos, Ph.D., M.P.H., R.N.
Steel, Jennifer L.

University Of Pittsburgh At Pittsburgh
United States

Palliative care intervention for socioeconomically disadvantaged cancer patients 5R01CA196953-05 Diane St Germain, R.N., M.S., C.R.N.P.
Staff, Nathan P

Mayo Clinic Rochester
United States

Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity 1R01CA275870-01 PAR-21-329 (R01 Clinical Trial Optional) Alexis Bakos, Ph.D., M.P.H., R.N.